GH
FOLD

GAM Holding’s Amicus Therapeutics FOLD Stock Holding History

GAM Holding’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-60,100
Closed -$583K – 991
2015
Q4 		$583K Buy
60,100
+12,000
+25% +$108K 0.01% 812
2015
Q3 		$673K Buy
+48,100
New +$754K 0.01% 778
2013
Q4 		– Sell
-31,700
Closed -$74K – 940
2013
Q3 		$74K Buy
+31,700
New +$79.5K ﹤0.01% 1091

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM Holding's FOLD Position: Q1 2016 in Review

GAM Holding sold out of Amicus Therapeutics (FOLD) in Q1 2016, closing a stake of 60,100 shares — an estimated $583K sold.

GAM Holding first reported a position in FOLD in Q3 2013 and held it in 3 quarters. The position peaked at $673K in Q3 2015. 128 funds tracked by Wall St. Rank hold FOLD as of Q1 2016.

  • GAM Holding reported no remaining Amicus Therapeutics position as of Q1 2016 after selling out during the quarter.
  • GAM Holding sold 60,100 Amicus Therapeutics shares in Q1 2016, an estimated $583K.
  • GAM Holding first reported a position in Amicus Therapeutics in Q3 2013 and held it in 3 quarters.
  • GAM Holding's Amicus Therapeutics position peaked at $673K in Q3 2015.
  • 128 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2016.

Based on GAM Holding's 13F filing for Q1 2016, filed 13 May 2016.